AARON DAHL: Open Payments
NPI 1891172813 · GILBERT, AZ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,652 in 148 payments from 20 companies in 2025. Trend: 2023 $2,204 · 2024 $2,511 · 2025 $2,652
Food & beverage: $2,652
| Company | Payments | Amount |
|---|---|---|
| Corium, LLC | 21 | $450 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 22 | $375 |
| Otsuka America Pharmaceutical, Inc. | 17 | $319 |
| ABBVIE INC. | 27 | $319 |
| Axsome Therapeutics, Inc. | 11 | $221 |
| Takeda Pharmaceuticals U.S.A., Inc. | 11 | $153 |
| Teva Pharmaceuticals USA, Inc. | 5 | $108 |
| Supernus Pharmaceuticals, Inc. | 5 | $103 |
| Collegium Pharmaceutical, Inc. | 5 | $100 |
| Vanda Pharmaceuticals Inc. | 4 | $85 |
Products named: Azstarys, CAPLYTA, VRAYLAR, ABILIFY ASIMTUFII, Auvelity, REXULTI, TRINTELLIX, AUSTEDO XR.
Industry payments across AZ — which companies pay providers there.
